What is he best known for?
The fields of study he is best known for:
Cancer research, Pathology, Cancer, Adenocarcinoma and KRAS are his primary areas of study.
The various areas that Marc Ladanyi examines in his Cancer research study include Mutation, Genetics, Gene and Epidermal growth factor receptor, Gefitinib.
His research investigates the link between Pathology and topics such as TFE3 that cross with problems in Clear cell.
His Lung cancer research extends to the thematically linked field of Cancer.
His research in Adenocarcinoma tackles topics such as Lung which are related to areas like Young adult.
Marc Ladanyi has researched KRAS in several fields, including V600E, Oncology and MAPK/ERK pathway.
His most cited work include:
- Comprehensive molecular portraits of human breast tumours (7253 citations)
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways (5484 citations)
- Comprehensive molecular characterization of human colon and rectal cancer (5012 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Cancer research, Pathology, Cancer, Internal medicine and Oncology.
His studies deal with areas such as Epidermal growth factor receptor, Mutation, KRAS, Gene and Lung cancer as well as Cancer research.
His work in KRAS is not limited to one particular discipline; it also encompasses Adenocarcinoma.
His Gene research entails a greater understanding of Genetics.
His biological study spans a wide range of topics, including Fluorescence in situ hybridization and Chromosomal translocation.
His work deals with themes such as Germline, Lung and DNA sequencing, which intersect with Oncology.
He most often published in these fields:
- Cancer research (41.81%)
- Pathology (26.34%)
- Cancer (20.21%)
What were the highlights of his more recent work (between 2018-2021)?
- Cancer research (41.81%)
- Internal medicine (19.30%)
- Oncology (18.68%)
In recent papers he was focusing on the following fields of study:
Marc Ladanyi spends much of his time researching Cancer research, Internal medicine, Oncology, Cancer and Pathology.
Marc Ladanyi has included themes like Mutation, Gene, Mutant, MAPK/ERK pathway and Adenocarcinoma in his Cancer research study.
His work carried out in the field of Internal medicine brings together such families of science as DNA sequencing and Exon.
His Cancer study combines topics in areas such as Myeloid, Drug resistance and Pan cancer.
His Pathology research is multidisciplinary, incorporating perspectives in RNA and DNA methylation.
His study looks at the relationship between Lung cancer and fields such as KRAS, as well as how they intersect with chemical problems.
Between 2018 and 2021, his most popular works were:
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types. (848 citations)
- High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants. (154 citations)
- Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer (121 citations)
In his most recent research, the most cited papers focused on:
His primary areas of study are Cancer research, Internal medicine, Cancer, Lung and Pathology.
His study in Cancer research is interdisciplinary in nature, drawing from both Immunohistochemistry, Mutation, Gene, Mutant and Lung cancer.
His research investigates the connection between Internal medicine and topics such as Oncology that intersect with issues in Prospective cohort study, Disease and Increased risk.
His Cancer research is multidisciplinary, incorporating elements of CHEK2, Myeloid, Haploinsufficiency, Allele and Drug resistance.
His research on Lung also deals with topics like
- Blockade and related Biomarker and Adenocarcinoma,
- Immunotherapy that connect with fields like Histology,
- Targeted therapy that intertwine with fields like Circulating tumor DNA, Prospective data and Concordance.
He interconnects Methylation and DNA methylation in the investigation of issues within Pathology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
